Home LiteratureArticle Details
PMID: 16869771 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.

Cold Spring Harbor symposia on quantitative biology ·Vol. 70 ·2005-00-00 ·Pages 343-56

Bissell MJ, Kenny PA, Radisky DC

Abstract

It is now widely accepted that elements of the cellular and tissue microenvironment are crucial regulators of cell behavior in culture and homeostasis in vivo, and that many of the same factors influence the course of tumor progression. Less well established is the extent to which extracellular factors actually cause cancer, and the circumstances under which this may occur. Using physiologically relevant three-dimensional culture assays and transgenic animals, we have explored how the environmental and architectural context of cells, tissues, and organs controls mammary-specific gene expression, growth regulation, apoptosis, and drug resistance and have found that loss of tissue structure is a prerequisite for cancer progression. Here we summarize this evidence and highlight two of our recent studies. Using mouse mammary epithelial cells, we show that exposure to matrix metalloproteinase-3 (MMP-3) stimulates production of reactive oxygen species (ROS) that destabilize the genome and induce epithelial-mesenchymal transition, causing malignant transformation. Using a human breast cancer progression series, we find that ADAM-dependent growth factor shedding plays a crucial role in acquisition of the malignant phenotype. These findings illustrate how normal tissue structure controls the response to extracellular signals so as to preserve tissue specificity and growth status.

MeSH Terms
Animals Breast/pathology,physiopathology Breast Neoplasms/etiology,pathology,physiopathology Cell Shape Cell Transformation, Neoplastic Extracellular Matrix/enzymology,pathology,physiology Female Humans Mammary Glands, Animal/pathology,physiopathology Mammary Neoplasms, Experimental/etiology,pathology,physiopathology Metalloproteases/genetics Mice Neoplasms/etiology,pathology,physiopathology Oncogenes Polymorphism, Genetic Signal Transduction
Chemicals
Metalloproteases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bissell M J
Cancer Biology Department, Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, 94720, USA.
Kenny P A
Radisky D C
References (126)
126 references, click to expand
  1. Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
    Science. 2002 Mar 29;295(5564):2387-92 PMID: 11923519
  2. New functions for the matrix metalloproteinases in cancer progression.
    Nat Rev Cancer. 2002 Mar;2(3):161-74 PMID: 11990853
  3. The snail superfamily of zinc-finger transcription factors.
    Nat Rev Mol Cell Biol. 2002 Mar;3(3):155-66 PMID: 11994736
  4. The promise and perils of Wnt signaling through beta-catenin.
    Science. 2002 May 31;296(5573):1644-6 PMID: 12040179
  5. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma.
    Genes Immun. 2002 Jun;3(4):229-32 PMID: 12058259
  6. Influence of cytokine gene polymorphisms on the development of prostate cancer.
    Cancer Res. 2002 Jun 15;62(12):3369-72 PMID: 12067976
  7. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases.
    J Cell Biol. 2002 Jul 22;158(2):357-68 PMID: 12119354
  8. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
    Leukemia. 2002 Aug;16(8):1437-42 PMID: 12145682
  9. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity.
    J Cell Biol. 1991 Dec;115(5):1383-95 PMID: 1955479
  10. A novel transcriptional enhancer is involved in the prolactin- and extracellular matrix-dependent regulation of beta-casein gene expression.
    Mol Biol Cell. 1992 Jun;3(6):699-709 PMID: 1498370
  11. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.
    Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9064-8 PMID: 1384042
  12. Extracellular matrix regulates expression of the TGF-beta 1 gene.
    J Cell Biol. 1993 Jan;120(1):253-60 PMID: 8416992
  13. Multi-faceted regulation of cell differentiation by extracellular matrix.
    FASEB J. 1993 Jun;7(9):737-43 PMID: 8330681
  14. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression.
    J Cell Biol. 1994 May;125(3):681-93 PMID: 8175886
  15. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix.
    Science. 1995 Feb 10;267(5199):891-3 PMID: 7531366
  16. The tumor-promoting effect of wounding: a possible role for TGF-beta-induced stromal alterations.
    Crit Rev Oncog. 1994;5(2-3):297-311 PMID: 7849089
  17. Oxidant signals and oxidative stress.
    Curr Opin Cell Biol. 2003 Apr;15(2):247-54 PMID: 12648682
  18. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma.
    Leuk Lymphoma. 2003 Feb;44(2):251-5 PMID: 12688341
  19. Modeling tissue-specific signaling and organ function in three dimensions.
    J Cell Sci. 2003 Jun 15;116(Pt 12):2377-88 PMID: 12766184
  20. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.
    Cancer Res. 2003 Jun 15;63(12):3066-8 PMID: 12810629
  21. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan.
    Int J Oncol. 2003 Aug;23(2):421-7 PMID: 12851691
  22. Genetic polymorphisms of platelet adhesive molecules: association with breast cancer risk and clinical presentation.
    Breast Cancer Res Treat. 2003 Jul;80(2):145-54 PMID: 12908817
  23. From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family.
    Nat Rev Genet. 2003 Oct;4(10):763-73 PMID: 14526373
  24. A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression.
    Cancer Lett. 2003 Oct 8;200(1):49-55 PMID: 14550952
  25. 10.5-kb homozygote of tumor necrosis factor-beta gene is associated with a better prognosis in gastric cancer patients.
    Cancer. 1995 Mar 15;75(6 Suppl):1450-3 PMID: 7889473
  26. Laminin mediates tissue-specific gene expression in mammary epithelia.
    J Cell Biol. 1995 May;129(3):591-603 PMID: 7730398
  27. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.
    J Cell Sci. 1995 Mar;108 ( Pt 3):985-1002 PMID: 7542672
  28. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression.
    Curr Opin Cell Biol. 1995 Oct;7(5):736-47 PMID: 8573350
  29. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.
    Physiol Rev. 1996 Jan;76(1):69-125 PMID: 8592733
  30. Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal.
    Cancer Res. 1996 May 1;56(9):2039-44 PMID: 8616848
  31. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties.
    J Biol Chem. 1997 Feb 21;272(8):5007-15 PMID: 9030563
  32. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.
    J Cell Biol. 1997 Apr 7;137(1):231-45 PMID: 9105051
  33. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
    Cancer Res. 2000 May 1;60(9):2562-6 PMID: 10811140
  34. Searching for genetic determinants in the new millennium.
    Nature. 2000 Jun 15;405(6788):847-56 PMID: 10866211
  35. Molecular mechanisms of development of the gastrointestinal tract.
    Dev Dyn. 2000 Oct;219(2):109-20 PMID: 11002332
  36. Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids.
    Methods Cell Biol. 2001;64:211-33 PMID: 11070841
  37. MMP1 and MMP3 polymorphisms in promoter regions and cancer.
    Clin Chem. 2000 Dec;46(12):2023-4 PMID: 11106348
  38. Molecular regulation of lung development.
    Annu Rev Physiol. 2001;63:471-94 PMID: 11181964
  39. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.
    Cancer Res. 2001 Feb 1;61(3):984-90 PMID: 11221894
  40. Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma.
    Cancer. 2001 Feb 15;91(4):672-8 PMID: 11241233
  41. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism.
    Cancer Res. 2001 Feb 15;61(4):1296-8 PMID: 11245423
  42. Induction of embryonic primordia by implantation of organizers from a different species. 1923.
    Int J Dev Biol. 2001;45(1):13-38 PMID: 11291841
  43. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness.
    Clin Cancer Res. 2001 Aug;7(8):2344-6 PMID: 11489811
  44. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions.
    Hum Mol Genet. 2001 Sep 1;10(18):1907-13 PMID: 11555627
  45. How matrix metalloproteinases regulate cell behavior.
    Annu Rev Cell Dev Biol. 2001;17:463-516 PMID: 11687497
  46. Presence of genetic alterations in microdissected stroma of human colon and breast cancers.
    Anticancer Res. 2001 Jul-Aug;21(4A):2259-64 PMID: 11724280
  47. Free radicals in the physiological control of cell function.
    Physiol Rev. 2002 Jan;82(1):47-95 PMID: 11773609
  48. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.
    J Cell Sci. 2002 Jan 1;115(Pt 1):39-50 PMID: 11801722
  49. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.
    J Pathol. 2002 Mar;196(3):254-65 PMID: 11857487
  50. Epithelial-mesenchymal transitions in tumour progression.
    Nat Rev Cancer. 2002 Jun;2(6):442-54 PMID: 12189386
  51. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.
    Cancer Cell. 2002 Sep;2(3):205-16 PMID: 12242153
  52. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome.
    Blood. 2002 Oct 15;100(8):3037-40 PMID: 12351419
  53. Interleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients.
    Melanoma Res. 2002 Oct;12(5):465-9 PMID: 12394188
  54. Role of genetic polymorphisms in tumour angiogenesis.
    Br J Cancer. 2002 Nov 4;87(10):1057-65 PMID: 12402142
  55. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.
    Nat Genet. 2002 Nov;32(3):355-7 PMID: 12379854
  56. A myogenic differentiation checkpoint activated by genotoxic stress.
    Nat Genet. 2002 Dec;32(4):585-93 PMID: 12415271
  57. Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor.
    Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1943-8 PMID: 12576544
  58. The role of Notch in tumorigenesis: oncogene or tumour suppressor?
    Nat Rev Cancer. 2003 Oct;3(10):756-67 PMID: 14570040
  59. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
    Cancer. 2003 Nov 1;98(9):1830-6 PMID: 14584063
  60. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
    Cancer Res. 2003 Nov 15;63(22):8051-6 PMID: 14633738
  61. Tissue architecture: the ultimate regulator of breast epithelial function.
    Curr Opin Cell Biol. 2003 Dec;15(6):753-62 PMID: 14644202
  62. Tumor-related alternatively spliced Rac1b is not regulated by Rho-GDP dissociation inhibitors and exhibits selective downstream signaling.
    J Biol Chem. 2003 Dec 12;278(50):50442-8 PMID: 14506233
  63. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.
    Cancer Res. 2003 Dec 15;63(24):8827-36 PMID: 14695199
  64. Tumour-educated macrophages promote tumour progression and metastasis.
    Nat Rev Cancer. 2004 Jan;4(1):71-8 PMID: 14708027
  65. Hedgehog signalling in cancer formation and maintenance.
    Nat Rev Cancer. 2003 Dec;3(12):903-11 PMID: 14737121
  66. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.
    Int J Cancer. 2004 Mar 20;109(2):247-52 PMID: 14750176
  67. Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase.
    J Biol Chem. 2004 Feb 6;279(6):4743-9 PMID: 14625275
  68. Cancer. Respect thy neighbor!
    Science. 2004 Feb 6;303(5659):775-7 PMID: 14764858
  69. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.
    Science. 2004 Feb 6;303(5659):848-51 PMID: 14764882
  70. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells.
    J Cell Biol. 2004 Feb 16;164(4):603-12 PMID: 14769856
  71. Common gene polymorphisms, cancer progression and prognosis.
    Cancer Lett. 2004 May 10;208(1):1-33 PMID: 15105042
  72. Molecular characterization of the tumor microenvironment in breast cancer.
    Cancer Cell. 2004 Jul;6(1):17-32 PMID: 15261139
  73. Reprogramming of a melanoma genome by nuclear transplantation.
    Genes Dev. 2004 Aug 1;18(15):1875-85 PMID: 15289459
  74. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Philos Trans R Soc Lond B Biol Sci. 2004 May 29;359(1445):839-50 PMID: 15293811
  75. Epithelial-stromal interactions in the mouse and human mammary gland in vivo.
    Endocr Relat Cancer. 2004 Sep;11(3):437-58 PMID: 15369447
  76. Recent genetic studies of mouse kidney development.
    Curr Opin Genet Dev. 2004 Oct;14(5):550-7 PMID: 15380247
  77. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate.
    Am J Pathol. 2004 Oct;165(4):1395-400 PMID: 15466403
  78. The road to Src.
    Oncogene. 2004 Oct 18;23(48):7910-7 PMID: 15489909
  79. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets.
    Cancer Res. 2004 Oct 15;64(20):7231-6 PMID: 15492239
  80. Breast cancer: induction of differentiation by embryonic tissue.
    Science. 1973 Sep 14;181(4104):1057-8 PMID: 4269415
  81. Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
    Proc Natl Acad Sci U S A. 1975 Sep;72(9):3585-9 PMID: 1059147
  82. Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations.
    Exp Cell Res. 1975 Aug;94(1):70-8 PMID: 243
  83. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
    Cancer Res. 1976 Aug;36(8):2720-5 PMID: 1064466
  84. Mesenchyme-dependent morphogenesis and epithelium-specific cytodifferentiation in mouse mammary gland.
    Science. 1976 Dec 24;194(4272):1439-41 PMID: 827022
  85. Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes.
    In Vitro. 1977 May;13(5):316-28 PMID: 559643
  86. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells.
    J Biol Chem. 1979 Sep 10;254(17):8679-89 PMID: 381311
  87. The differentiated state of normal and malignant cells or how to define a "normal" cell in culture.
    Int Rev Cytol. 1981;70:27-100 PMID: 7228573
  88. How does the extracellular matrix direct gene expression?
    J Theor Biol. 1982 Nov 7;99(1):31-68 PMID: 6892044
  89. Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata.
    J Cell Biol. 1984 Jan;98(1):146-55 PMID: 6707082
  90. Inability of Rous sarcoma virus to cause sarcomas in the avian embryo.
    Nature. 1984 Jun 7-13;309(5968):552-6 PMID: 6203040
  91. Interaction of mouse mammary epithelial cells with collagen substrata: regulation of casein gene expression and secretion.
    Proc Natl Acad Sci U S A. 1985 Mar;82(5):1419-23 PMID: 3856271
  92. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study.
    Cancer. 1985 Aug 1;56(3):531-8 PMID: 2408737
  93. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
    N Engl J Med. 1986 Dec 25;315(26):1650-9 PMID: 3537791
  94. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium.
    In Vitro Cell Dev Biol. 1987 Mar;23(3):181-8 PMID: 3558253
  95. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.
    Br J Cancer. 1987 Dec;56(6):814-9 PMID: 2829956
  96. pp60v-src tyrosine kinase is expressed and active in sarcoma-free avian embryos microinjected with Rous sarcoma virus.
    Proc Natl Acad Sci U S A. 1988 Oct;85(20):7587-91 PMID: 2845414
  97. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.
    Cancer. 1989 Jan 15;63(2):381-5 PMID: 2910445
  98. The distribution of secondary growths in cancer of the breast. 1889.
    Cancer Metastasis Rev. 1989 Aug;8(2):98-101 PMID: 2673568
  99. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.
    Development. 1989 Feb;105(2):223-35 PMID: 2806122
  100. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.
    Proc Natl Acad Sci U S A. 1990 Jan;87(1):75-9 PMID: 2296606
  101. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta.
    Science. 1990 Jun 29;248(4963):1656-60 PMID: 2163544
  102. The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia.
    J Cell Biol. 1990 Jul;111(1):217-28 PMID: 2164029
  103. Influence of male genital tract mesenchymes on differentiation of Dunning prostatic adenocarcinoma.
    Cancer Res. 1990 Aug 1;50(15):4747-54 PMID: 2369750
  104. Differentiation requires continuous regulation.
    J Cell Biol. 1991 Mar;112(5):781-3 PMID: 1999456
  105. Designer microenvironments for the analysis of cell and tissue function.
    Curr Opin Cell Biol. 1990 Oct;2(5):864-74 PMID: 2083086
  106. Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors.
    Hum Cell. 1996 Dec;9(4):257-64 PMID: 9183656
  107. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.
    J Cell Biol. 1997 Dec 29;139(7):1861-72 PMID: 9412478
  108. Characterization of BCE-1, a transcriptional enhancer regulated by prolactin and extracellular matrix and modulated by the state of histone acetylation.
    Mol Cell Biol. 1998 Apr;18(4):2184-95 PMID: 9528790
  109. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change.
    Science. 1998 May 8;280(5365):898-902 PMID: 9572733
  110. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
    Blood. 1998 May 15;91(10):3574-81 PMID: 9572991
  111. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14821-6 PMID: 9843973
  112. Tissue structure, nuclear organization, and gene expression in normal and malignant breast.
    Cancer Res. 1999 Apr 1;59(7 Suppl):1757-1763s; discussion 1763s-1764s PMID: 10197593
  113. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.
    Cell. 1999 Jul 23;98(2):137-46 PMID: 10428026
  114. Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells.
    Mol Biol Cell. 1999 Sep;10(9):2817-28 PMID: 10473629
  115. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region.
    Cancer Res. 1999 Sep 1;59(17):4225-7 PMID: 10485461
  116. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.
    Cancer Res. 1999 Oct 1;59(19):5002-11 PMID: 10519415
  117. Association studies for finding cancer-susceptibility genetic variants.
    Nat Rev Cancer. 2004 Nov;4(11):850-60 PMID: 15516958
  118. CYTODIFFERENTIATION AND ITS CONTROLS.
    Science. 1964 Feb 14;143(3607):643-50 PMID: 14081236
  119. Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas.
    Breast Cancer Res Treat. 2004 Nov;88(2):131-9 PMID: 15564796
  120. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.
    J Steroid Biochem Mol Biol. 2004 Nov;92(4):221-36 PMID: 15663986
  121. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.
    Cancer Res. 2005 Mar 1;65(5):1627-30 PMID: 15753354
  122. Soluble mediators of inflammation during tumor development.
    Adv Cancer Res. 2005;93:159-87 PMID: 15797447
  123. Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors.
    Br J Cancer. 2005 May 23;92(10):1922-6 PMID: 15841079
  124. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability.
    Nature. 2005 Jul 7;436(7047):123-7 PMID: 16001073
  125. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.
    Genes Dev. 2005 Aug 15;19(16):1934-50 PMID: 16103220
  126. Myoepithelial cells: good fences make good neighbors.
    Breast Cancer Res. 2005;7(5):190-7 PMID: 16168137
Article Info
Journal
Cold Spring Harbor symposia on quantitative biology
Abbr.
Cold Spring Harb Symp Quant Biol
ISSN
0091-7451
Published
2005-00-00
Pages
343-56
Language
English
Region
United States
NLM ID
1256107
PMCID
PMC3004779
Subset
IM
Grants
NCI NIH HHS · 2 R01 CA064786-09 · United States
NCI NIH HHS · R01 CA064786-09 · United States
NCI NIH HHS · R01 CA057621 · United States
NCI NIH HHS · CA57621 · United States
NCI NIH HHS · R01 CA064786 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]